The reservoir for Neisseria meningitidis (Nm) is the human oropharynx. Implementation of Nm serogroup C (NmC) glycoconjugate vaccines directly reduced NmC carriage. Prophy-lactic vaccines are now available to prevent disease caused by the five major Nm disease causing serogroups (ABCWY). Nm serogroup B (NmB) vaccines are composed of antigens that are conserved across Nm serogroups and therefore have the potential to impact all Nm carriage. To assess the effect of these vaccines on carriage, standardized approaches to identify and group Nm are required. Real-time PCR (rt-PCR) capsule grouping assays that were internally controlled to confirm Nm species were developed for eight serogroups asso
Developing effective vaccines against Neisseria meningitidis serogroup B has been challenging for se...
International audienceA new vaccine, 4CMenB, is composed of surface proteins of Neisseria meningitid...
Comment in: Toward an Improved Meningococcal Serogroup B Assay. [MBio. 2018]International audienceBi...
<div><p>The reservoir for <i>Neisseria meningitidis</i> (Nm) is the human oropharynx. Implementation...
The reservoir for Neisseria meningitidis (Nm) is the human oropharynx. Implementation of Nm serogrou...
To access publisher's full text version of this article click on the hyperlink belowImproved underst...
Neisseria meningitidis (Nm) disease occurs worldwide. Disease incidence rates can vary from 1 to 10...
Meningococcal disease is a life-threatening illness with annual incidence rates varying from 1 to 10...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
is a major cause of bacterial meningitis and aNeisseria meningitidis considerable health problem in ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
PURPOSE OF REVIEW: Meningococcal disease is a severe consequence of infection with Neisseria meningi...
Meningococcal disease is communicable by close contact or droplet aerosols. Striking features are hi...
Herd protection, resulting from the interruption of transmission and asymptomatic carriage, is an im...
Following the introduction of effective protein-polysaccharide conjugate vaccines against capsular g...
Developing effective vaccines against Neisseria meningitidis serogroup B has been challenging for se...
International audienceA new vaccine, 4CMenB, is composed of surface proteins of Neisseria meningitid...
Comment in: Toward an Improved Meningococcal Serogroup B Assay. [MBio. 2018]International audienceBi...
<div><p>The reservoir for <i>Neisseria meningitidis</i> (Nm) is the human oropharynx. Implementation...
The reservoir for Neisseria meningitidis (Nm) is the human oropharynx. Implementation of Nm serogrou...
To access publisher's full text version of this article click on the hyperlink belowImproved underst...
Neisseria meningitidis (Nm) disease occurs worldwide. Disease incidence rates can vary from 1 to 10...
Meningococcal disease is a life-threatening illness with annual incidence rates varying from 1 to 10...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
is a major cause of bacterial meningitis and aNeisseria meningitidis considerable health problem in ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
PURPOSE OF REVIEW: Meningococcal disease is a severe consequence of infection with Neisseria meningi...
Meningococcal disease is communicable by close contact or droplet aerosols. Striking features are hi...
Herd protection, resulting from the interruption of transmission and asymptomatic carriage, is an im...
Following the introduction of effective protein-polysaccharide conjugate vaccines against capsular g...
Developing effective vaccines against Neisseria meningitidis serogroup B has been challenging for se...
International audienceA new vaccine, 4CMenB, is composed of surface proteins of Neisseria meningitid...
Comment in: Toward an Improved Meningococcal Serogroup B Assay. [MBio. 2018]International audienceBi...